AIR Inhaled Insulin Versus Subcutaneous Insulin

Diabetes Care

Volumn 31, Issue 4, 2008, Pages 735-740

  Wolzt, Michael ^a   De La Peña, Amparo ^b   Berclaz, Pierre Yves ^b   Tibaldi, Fabián S ^b   Gates, Jeffrey R ^b   Muchmore, Douglas B ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIR INSULIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; INSULIN; INSULIN LISPRO; SALBUTAMOL; UNCLASSIFIED DRUG; ANTIASTHMATIC AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; AREA UNDER THE CURVE; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE SEVERITY; DIZZINESS; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG EXPOSURE; DRUG RESPONSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; FEMALE; GLUCOSE CLAMP TECHNIQUE; HEADACHE; HUMAN; LUNG DISEASE; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; OPEN STUDY; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; BLOOD; FORCED EXPIRATORY VOLUME; GLUCOSE BLOOD LEVEL; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION; VITAL CAPACITY;

ADMINISTRATION, INHALATION; ADULT; ALBUTEROL; ANTI-ASTHMATIC AGENTS; ASTHMA; BLOOD GLUCOSE; CROSS-OVER STUDIES; FORCED EXPIRATORY VOLUME; GLUCOSE CLAMP TECHNIQUE; HUMANS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; VITAL CAPACITY;

EID: 48649104566     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-0873     Document Type: Article

References (17)

1. Cefalu WT: Concept, strategies, and feasibility of noninvasive insulin delivery. Diabetes Care 27:239-246, 2004
2. Lenzer J: Inhaled insulin is approved in Europe and United States. BMJ 332:321, 2006
3. Muchmore DB, Gates JR: Inhaled insulin delivery: where are we now? Diabetes Obes Metab 8:634-642, 2006
4. Hayes RP, Bowman L, Monahan PO, Marrero DG, McHorney CA: Understanding diabetes medications from the perspective of patients with type 2 diabetes: prerequisite to medication concordance. Diabetes Educ 32:404-414, 2006
5. Edwards DA, Hanes J, Caponetti G, Hrkach J, Ben-Jebria A, Eskew ML, Mintzes J, Deaver D, Lotan N, Langer R: Large porous particles for pulmonary drug delivery. Science 276:1868-1871, 1997
6. Odegard PS, Capoccia KL: Inhaled insulin: exubera. Ann Pharmacother 39:843-853, 2005
7. Rave KM, Nosek L, de la Peña A, Seger M, Ernest CS, Heinemann L, Batycky RP, Muchmore DB: Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro. Diabetes Care 28:2400-2405, 2005
8. O'Riordan TG, Walser L, Smaldone GC: Changing patterns of aerosol deposition during methacholine bronchoprovocation. Chest 103:1385-1389, 1993
9. Del Donno M, Chetta A, Foresi A, Gavaruzzi G, Ugolotti G, Olivieri D: Lung epithelial permeability and bronchial responsiveness in subjects with stable asthma. Chest 111:1255-1260, 1997
10. Laube BL: Treating diabetes with aerosolized insulin. Chest 120 (Suppl. 3):99S-106S, 2001
11. Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma. National Asthma Education and Prevention Program. Bethesda, MD, National Institutes of Health, 1997 (NIH publ. no. 97-4051)
12. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
13. Hermansen K, Rönnemaa T, Petersen AH, Bellaire S, Adamson U: Intensive therapy with inhaled insulin via the AERx Insulin Diabetes Management System: a 12-week proof-of-concept trial in patients with type 2 diabetes. Diabetes Care 27:162-167, 2004
14. Hollander PA, Blonde L, Rowe R, Mehta AE, Milburn JL, Hershon KS, Chiasson J-L, Levin SR: Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial Diabetes Care 27:2356-2362, 2004
15. Skyler JS, Weinstock RS, Raskin P, Yale J-F, Barrett E, Gerich JE, Gerstein HC, the Inhaled Insulin Phase III Type 1 Diabetes Study Group: Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial. Diabetes Care 28:1630-1635, 2005
16. Henry RR, Mudaliar SRD, Howland WC, Chu N, Kim D, An B, Reinhardt RR: Inhaled insulin using the AERx Insulin Diabetes Management System in healthy and asthmatic subjects. Diabetes Care 26: 764-769, 2003
17. Teeter JG, Foutaine R, Milton A, Wei G, Checchio T, Stolar M, Fryburg DA: Effects of albuterol and fluticasone on inhaled human insulin (Exubera) pharmacokinetics in subjects with mild-to-moderate asthma. Parts of this article were presented in abstract form at the European Association for the Study of Diabetes 42nd Annual Meeting, Copenhagen, Denmark, 14 -17 September 2006